Intellia Therapeutics, Inc.NTLANASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-3.25%
↓ 107% below average
Average (39q)
46.16%
Historical baseline
Range
High:1609.39%
Low:-115.99%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -3.25% |
| Q2 2025 | -14.33% |
| Q1 2025 | 29.15% |
| Q4 2024 | 41.30% |
| Q3 2024 | 30.96% |
| Q2 2024 | -75.96% |
| Q1 2024 | 1609.39% |
| Q4 2023 | -115.99% |
| Q3 2023 | -11.78% |
| Q2 2023 | 7.84% |
| Q1 2023 | -7.12% |
| Q4 2022 | 2.31% |
| Q3 2022 | -5.45% |
| Q2 2022 | 24.69% |
| Q1 2022 | -12.46% |
| Q4 2021 | 78.43% |
| Q3 2021 | 9.98% |
| Q2 2021 | 1.63% |
| Q1 2021 | -2.27% |
| Q4 2020 | -70.32% |
| Q3 2020 | 36.63% |
| Q2 2020 | 25.91% |
| Q1 2020 | 18.11% |
| Q4 2019 | 3.01% |
| Q3 2019 | -4.52% |
| Q2 2019 | 6.57% |
| Q1 2019 | 32.40% |
| Q4 2018 | 6.37% |
| Q3 2018 | -3.50% |
| Q2 2018 | 2.78% |
| Q1 2018 | 12.01% |
| Q4 2017 | -8.87% |
| Q3 2017 | 23.66% |
| Q2 2017 | -4.79% |
| Q1 2017 | 10.45% |
| Q4 2016 | 15.57% |
| Q3 2016 | 15.76% |
| Q2 2016 | 136.69% |
| Q1 2016 | 4.96% |
| Q4 2015 | 0.30% |